Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cardiol Therapeutics (CRDL)
Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,005
  • Shares Outstanding, K 64,778
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,790 K
  • 60-Month Beta 0.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.00
Trade CRDL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings -0.09 on 08/10/23
  • Next Earnings Date 11/09/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 1,073.57% ( +603.31%)
  • Historical Volatility 65.50%
  • IV Percentile 99%
  • IV Rank 77.51%
  • IV High 1,365.74% on 07/13/23
  • IV Low 66.66% on 10/20/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 33
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,384
  • Open Int (30-Day) 1,328

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +999,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +5.33%
on 10/03/23
1.0700 -26.17%
on 09/21/23
-0.2100 (-21.00%)
since 09/01/23
3-Month
0.7500 +5.33%
on 10/03/23
1.2353 -36.05%
on 08/03/23
-0.1051 (-11.74%)
since 07/03/23
52-Week
0.4500 +75.56%
on 04/06/23
1.2353 -36.05%
on 08/03/23
-0.2100 (-21.00%)
since 10/03/22

Most Recent Stories

More News
Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference

Toronto, Ontario--(Newsfile Corp. - September 26, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL : 0.7900 (-10.23%)
CRDL.TO : 1.06 (-8.62%)
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis

Recruitment Accelerating and Full Patient Enrollment Anticipated to be Completed During Q3 2024, up to Six Months Ahead of Schedule Multi-Center, International, Double-blind, Placebo-controlled Trial...

CRDL : 0.7900 (-10.23%)
CRDL.TO : 1.06 (-8.62%)
Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference

Toronto, Ontario--(Newsfile Corp. - August 9, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL.TO : 1.06 (-8.62%)
CRDL : 0.7900 (-10.23%)
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market

Oakville, Ontario--(Newsfile Corp. - August 8, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 1.06 (-8.62%)
CRDL : 0.7900 (-10.23%)
Cardiol Therapeutics Reports Results of 2023 Annual General Meeting

Oakville, Ontario--(Newsfile Corp. - June 29, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL.TO : 1.06 (-8.62%)
CRDL : 0.7900 (-10.23%)
Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx™ in patients with recurrent pericarditis - a debilitating heart...

CRDL.TO : 1.06 (-8.62%)
CRDL : 0.7900 (-10.23%)
Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure

Results Demonstrate Cannabidiol Improved Cardiac Function, Reduced its Inflammatory State, and Prevented the Development of Hypertrophy and Fibrosis in Heart TissueData Presented at The American College...

CRDL.TO : 1.06 (-8.62%)
CRDL : 0.7900 (-10.23%)
Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent Pericarditis

The Cleveland Clinic Recruits First Participant in the Multi-center U.S. StudyOakville, Ontario--(Newsfile Corp. - January 17, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or...

CRDL.TO : 1.06 (-8.62%)
CRDL : 0.7900 (-10.23%)
Here's Why Cardiol Therapeutics Inc. (CRDL) Could be Great Choice for a Bottom Fisher

Cardiol Therapeutics Inc. (CRDL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions...

CRDL : 0.7900 (-10.23%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...

CRDL : 0.7900 (-10.23%)
CRDL.TO : 1.06 (-8.62%)
JNJ : 155.34 (+0.12%)
TAK : 14.95 (-2.16%)
NVO : 87.78 (-4.38%)
BMY : 57.22 (-1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

See More

Key Turning Points

3rd Resistance Point 0.9767
2nd Resistance Point 0.9233
1st Resistance Point 0.8567
Last Price 0.7900
1st Support Level 0.7367
2nd Support Level 0.6833
3rd Support Level 0.6167

See More

52-Week High 1.2353
Fibonacci 61.8% 0.9353
Fibonacci 50% 0.8426
Last Price 0.7900
Fibonacci 38.2% 0.7500
52-Week Low 0.4500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar